Chhabria said that the startup’s FY25 revenue would be 95% higher than its revenue of INR 72 Cr in the previous fiscal year
The D2C nutraceutical brand will achieve EBITDA profitability in the ongoing January-March quarter of 2025 on the back of cost optimisation
Loss is expected to remain flat at around INR 31.8 Cr in FY25 as against INR 31.6 Cr in the previous fiscal year
D2C nutraceutical brand Wellbeing Nutrition is on track to close the ongoing financial year 2024-25 (FY25) with a revenue of INR 140 Cr, its…